Related Experiment Video
Updated: Jun 14, 2026
07:21
Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
Urotensin-II as an angiogenic factor
Diego Guidolin1, Giovanna Albertin, Domenico Ribatti
1Department of Human, Anatomy and Physiology (Section of Anatomy), University of Padova Medical School, Via Gabelli, 65, I-35121 Padova, Italy. diego.guidolin@unipd.it
Peptides
|March 30, 2010
Summary
Urotensin-II, a peptide hormone, plays a role in regulating angiogenesis, the formation of new blood vessels. This review examines its involvement in this complex biological process.
Area of Science:
- Physiology
- Molecular Biology
- Vascular Biology
Background:
- Angiogenesis is a vital process for development and disease, regulated by classic and nonclassic factors.
- Urotensin-II is a peptide hormone known for its potent vasoconstrictor and hypertensive effects.
- Nonclassic regulators are increasingly recognized for their roles in vascular biology.
Purpose of the Study:
- To review and summarize existing literature on the role of urotensin-II in angiogenesis.
- To highlight urotensin-II as a significant nonclassic regulator of blood vessel formation.
- To consolidate current knowledge on urotensin-II's angiogenic functions.
Main Methods:
- Literature review of scientific articles.
- Analysis of studies investigating urotensin-II's effects on endothelial cells.
- Synthesis of data from in vitro and in vivo angiogenesis models.
Main Results:
- Urotensin-II influences multiple aspects of angiogenesis.
- Evidence suggests urotensin-II can promote or inhibit blood vessel formation depending on context.
- Its role extends beyond vasoconstriction to direct modulation of angiogenic pathways.
Conclusions:
- Urotensin-II is implicated as a key player in the regulation of angiogenesis.
- Further research is warranted to fully elucidate urotensin-II's therapeutic potential in vascular diseases.
- Understanding urotensin-II's multifaceted role can offer new insights into angiogenic control.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...